Skip to main content
    I

    Immunic Inc (IMUX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $7.33
    +0.10 (+1.38%)

    Market Cap: $114.82M

    Last updated: Nov 17, 2026 at 4:16 PM ET

    Immunic Inc (IMUX) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Immunic (IMUX) has a latest price of $7.33 on Nov 17, 2026, 57.9% below its 52-week high of $17.43. Its price fell 5.8% over the past 12 months. The month-end price fell 99.6% over the 10 years through Oct 2026, a compound annual decline of 43.2%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $3,220.00 in Aug 2018 and its lowest $5.34 in Dec 2025, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart IMUX with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IMUX.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 55.4%, and over 6 months it fell 36.8%. The month-end price fell 29.2% over the 3 years through Oct 2026, a compound annual decline of 10.9%.

    PeriodChange
    1 month+4.9%
    3 months-55.4%
    6 months-36.8%
    12 months-5.8%
    12 months, with dividends-5.8%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-29.2%-10.9%
    5 years-91.9%-39.6%
    10 years-99.6%-43.2%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 57.6%, and its weakest was 2018, when it fell 96.9%.

    YearCloseChange
    2026 through Oct 2026$7.51+40.7%
    2025$5.34-46.6%
    2024$10.00-33.3%
    2023$15.00+7.1%
    2022$14.00-85.4%
    2021$95.70-37.4%
    2020$152.90+57.6%
    2019$97.00+30.2%
    2018$74.52-96.9%
    2017$2,380.00+36.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 13.5% below its 50-day average of $8.47 and 36.6% below its 200-day average of $11.57.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$7.33
    52-week high$17.43-57.9%
    52-week low$5.06+44.9%
    50-day average$8.47-13.5%
    200-day average$11.57-36.6%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 73.8%.

    MeasureValue
    1-year beta1.55
    Largest fall, 1 year-60.6%
    Largest fall, 3 years-73.8%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About IMUX

    What is IMUX's 1-year price change?

    Immunic's price fell 5.8% over the past 12 months. With dividends included, the 12-month total return was -5.8%.

    What is IMUX's 5-year price change?

    Immunic's month-end price fell 91.9% over the 5 years through Oct 2026, a compound annual decline of 39.6%. These figures leave out dividends.

    What is IMUX's 52-week high and low?

    Immunic's 52-week high is $17.43 and its 52-week low is $5.06. Its latest price of $7.33 on Nov 17, 2026 is 57.9% below the high.

    What is IMUX's beta?

    Immunic's 1-year beta against the S&P 500 is 1.55, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 60.6%.

    Is the IMUX chart free?

    Yes. Advanced Charting for IMUX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.